Aug 10, 2022 / 08:30PM GMT
Operator
Greetings, and welcome to the Adamis Pharmaceuticals' Second Quarter 2022 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Robert Uhl, ICR of Westwicke. Please proceed.
Robert H. Uhl - Westwicke Partners, LLC - MD
Thank you, operator. Welcome to the Adamis Pharmaceuticals' Second Quarter 2022 Financial Results and Corporate Update Conference Call. Thank you for joining us today for the update.
Joining me on the call will be members of the Adamis executive team, including in his new role, CEO, David J. Marguglio; Chief Medical Officer, Dr. Ron Moss; and Chief Financial Officer, David Benedicto. They will share with us their various Adamis updates.
Our format for this call will consist of prepared remarks from management. And following that, we will open it up to Q&A. This call is being webcast and will be available for replay in the Investors section of the Adamis website at adamispharmaceuticals.com.
In today's call, we will
Q2 2022 Adamis Pharmaceuticals Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot